Thyroid Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Ultrasonography May Detect Thyroid Cancer Growth Arrest, Negating Need for Treatment - Cancer Therapy Advisor



Cancer Therapy Advisor
 
Ultrasonography May Detect Thyroid Cancer Growth Arrest, Negating Need for Treatment 
Cancer Therapy Advisor
Researchers enrolled 116 patients who were diagnosed with or were suspected of having thyroid cancer. The authors measured the growths' change in diameter to determine a growth pattern. Thyroid cancer detected by ultrasonography may be ...

 


Interpace Diagnostics Wins NY State Approval for Thyroid Cancer Testing Service - GenomeWeb



Interpace Diagnostics Wins NY State Approval for Thyroid Cancer Testing Service 
GenomeWeb
NEW YORK (GenomeWeb) ? Interpace Diagnostics announced today that it has received approval from the New York State Department of Health (NYSDOH) for its TERT test offering, which is designed to detect a molecular biomarker of thyroid cancer ...

and more » 


Israeli researchers decode thyroid cancer treatment resistance mechanism - The Jerusalem Post



The Jerusalem Post
 
Israeli researchers decode thyroid cancer treatment resistance mechanism 
The Jerusalem Post
Researchers at Haifa's Rambam Medical Center and Technion-Israel Institute of Technology have decoded for the first time the mechanism that leads some thyroid-cancer patients to be unaffected by treatment, providing hope for more successful therapies ...

 


Immunotherapy, New Targeted Approaches Explored in Thyroid Cancer - OncLive



OncLive
 
Immunotherapy, New Targeted Approaches Explored in Thyroid Cancer 
OncLive
As with other solid tumors, researchers are now exploring both BRAF/MEK inhibitor combinations and PD-1 therapy in the field of thyroid cancer for patients who are refractory to radioactive-iodine treatment, according to Gregory Daniels, MD, PhD, who ...

 


TERT, BRAF Mutations Mean Poor Papillary Thyroid Cancer Outcomes - Medscape



Medscape
 
TERT, BRAF Mutations Mean Poor Papillary Thyroid Cancer Outcomes 
Medscape
VICTORIA, British Columbia ? The presence of a telomerase reverse transcriptase (TERT) promotor mutation, combined with the more common BRAF mutation, is associated with an increased risk of poorer outcomes in papillary thyroid cancer (PTC), ...

 


Researchers develop new diagnostic method for thyroid cancer - Korea Biomedical Review



Korea Biomedical Review
 
Researchers develop new diagnostic method for thyroid cancer 
Korea Biomedical Review
Researchers at the Catholic University Seoul St. Mary's Hospital?????? have developed a new test to diagnose thyroid cancer by using photoacoustic images, the hospital said Friday. Photoacoustic imaging is a technology that uses a photoacoustic ...

 


Precision medicine for ATC ? BRAF and MEK inhibition shows ... - Nature.com



Precision medicine for ATC ? BRAF and MEK inhibition shows ... 
Nature.com
Anaplastic thyroid carcinoma (ATC) is a rare malignancy (accounting for 1?2% of all thyroid cancers) that holds a dismal prognosis, with median overall survival ...

and more » 


NICE Rejects Treatments for Bladder and Thyroid Cancer - OncLive



OncLive
 
NICE Rejects Treatments for Bladder and Thyroid Cancer 
OncLive
The UK's National Institute for Health and Care Excellence (NICE) has issued guidelines recommending against nivolumab (Opdivo) for routine use in patients with previously-treated advanced urothelial carcinoma. The agency also recommended against ...

 


Is Overdiagnosis of Thyroid Ca a Problem in Teens? - MedPage Today



Is Overdiagnosis of Thyroid Ca a Problem in Teens? 
MedPage Today
"In adults, thyroid cancer generally grows very slowly and most of papillary thyroid microcarcinomas have been reported not to progress in some active surveillance studies. On our survey in Fukushima, thyroid ultrasound examination has brought multiple ...

 


Dr. Daniels Discusses Treatment Options in Thyroid Cancer - OncLive



OncLive
 
Dr. Daniels Discusses Treatment Options in Thyroid Cancer 
OncLive
The 2 FDA-approved agents for the treatment of patients with thyroid cancer are sorafenib (Nexavar) and lenvatinib (Lenvima). These are tyrosine kinase inhibitors that target VEGF1, VEGF2, and VEGF3, but these are not necessarily the driver mutations ...